IQVIA (NYSE:IQV) Sees Strong Trading Volume - Time to Buy?

Shares of IQVIA Holdings Inc. (NYSE:IQV - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 872,396 shares changed hands during trading, an increase of 53% from the previous session's volume of 569,620 shares.The stock last traded at $201.98 and had previously closed at $197.39.

Wall Street Analyst Weigh In

A number of research firms have commented on IQV. William Blair restated an "outperform" rating on shares of IQVIA in a research note on Wednesday, December 11th. TD Cowen lowered their target price on shares of IQVIA from $270.00 to $255.00 and set a "buy" rating on the stock in a research note on Friday, November 1st. Morgan Stanley cut their price target on IQVIA from $280.00 to $265.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. Redburn Atlantic assumed coverage on IQVIA in a research report on Monday, October 14th. They issued a "buy" rating and a $276.00 price objective on the stock. Finally, The Goldman Sachs Group cut their target price on IQVIA from $280.00 to $250.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $255.82.

IQVIA Stock Up 0.8 %

The stock has a market cap of $36.13 billion, a P/E ratio of 26.12, a price-to-earnings-growth ratio of 2.05 and a beta of 1.48. The company's fifty day moving average price is $202.86 and its 200-day moving average price is $222.14. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. First Foundation Advisors boosted its holdings in IQVIA by 3.8% during the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company's stock valued at $245,000 after acquiring an additional 43 shares during the period. Invera Wealth Advisors LLC increased its stake in IQVIA by 0.3% in the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company's stock worth $3,183,000 after buying an additional 46 shares during the period. Private Trust Co. NA lifted its holdings in IQVIA by 10.7% during the 3rd quarter. Private Trust Co. NA now owns 485 shares of the medical research company's stock valued at $115,000 after buying an additional 47 shares in the last quarter. Clear Harbor Asset Management LLC boosted its position in IQVIA by 1.3% in the 3rd quarter. Clear Harbor Asset Management LLC now owns 3,969 shares of the medical research company's stock valued at $941,000 after buying an additional 50 shares during the period. Finally, Pine Valley Investments Ltd Liability Co grew its stake in IQVIA by 0.5% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company's stock worth $2,247,000 after acquiring an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 89.62% of the company's stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.